ATE278401T1 - Verwendung von riluzol zur behandlung von akustischen traumazuständen - Google Patents

Verwendung von riluzol zur behandlung von akustischen traumazuständen

Info

Publication number: ATE278401T1
Authority: AT; Austria
Prior art keywords: riluzole; acoustic trauma; trauma conditions; treat acoustic; treat
Prior art date: 1998-12-15

Application number

AT99958307T

Other languages

English (en)

Inventor

Jean-Marie Stutzmann

John Randle

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-15

Filing date

1999-12-13

Publication date

2004-10-15

1999-12-13 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2004-10-15 Application granted granted Critical

2004-10-15 Publication of ATE278401T1 publication Critical patent/ATE278401T1/de

Links

206010011903 Deafness traumatic Diseases 0.000 title abstract 2
208000002946 Noise-Induced Hearing Loss Diseases 0.000 title abstract 2
FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 title abstract 2
229960004181 riluzole Drugs 0.000 title abstract 2
206010011878 Deafness Diseases 0.000 abstract 1
208000009205 Tinnitus Diseases 0.000 abstract 1
231100000895 deafness Toxicity 0.000 abstract 1
208000016354 hearing loss disease Diseases 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
231100000886 tinnitus Toxicity 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Saccharide Compounds (AREA)
Steroid Compounds (AREA)

AT99958307T 1998-12-15 1999-12-13 Verwendung von riluzol zur behandlung von akustischen traumazuständen ATE278401T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9815834A FR2787028B1 (fr)	1998-12-15	1998-12-15	Utilisation du riluzole dans le traitement des traumatismes acoustiques
PCT/FR1999/003108 WO2000035447A1 (fr)	1998-12-15	1999-12-13	Utilisation du riluzole dans le traitement des traumatismes acoustiques

Publications (1)

Publication Number	Publication Date
ATE278401T1 true ATE278401T1 (de)	2004-10-15

Family

ID=9533998

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99958307T ATE278401T1 (de)	1998-12-15	1999-12-13	Verwendung von riluzol zur behandlung von akustischen traumazuständen

Country Status (20)

Country	Link
US (1)	US6660757B2 (de)
EP (1)	EP1140080B1 (de)
JP (2)	JP4831866B2 (de)
KR (1)	KR100641473B1 (de)
AT (1)	ATE278401T1 (de)
AU (1)	AU773639B2 (de)
BR (1)	BR9916244A (de)
CA (1)	CA2355359C (de)
CZ (1)	CZ292078B6 (de)
DE (1)	DE69920959T2 (de)
ES (1)	ES2229796T3 (de)
FR (1)	FR2787028B1 (de)
HU (1)	HU228889B1 (de)
IL (2)	IL143280A0 (de)
NO (1)	NO326764B1 (de)
PT (1)	PT1140080E (de)
SK (1)	SK285206B6 (de)
UA (1)	UA72229C2 (de)
WO (1)	WO2000035447A1 (de)
ZA (1)	ZA200104827B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2787028B1 (fr) *	1998-12-15	2002-10-18	Aventis Pharma Sa	Utilisation du riluzole dans le traitement des traumatismes acoustiques
CA2673126A1 (en)	2006-10-13	2008-04-24	The University Of North Carolina At Chapel Hill	Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea
TW201039383A (en) *	2009-04-17	2010-11-01	Arima Optoelectronics Corp	Semiconductor chip electrode structure and manufacturing method thereof
EA201791110A1 (ru) *	2014-11-21	2017-11-30	Биохэвен Фармасьютикэл Холдинг Компани Лтд.	Сублингвальное введение рилузола
LT3220891T (lt)	2014-11-21	2019-11-11	Biohaven Therapeutics Ltd	Poliežuvinė riluzolio kompozicija
JP6999896B2 (ja)	2017-09-21	2022-01-19	学校法人慶應義塾	音響外傷難聴モデル動物の作製方法及びそれにより作製される音響外傷難聴モデル動物
WO2025133679A1 (en) *	2023-12-18	2025-06-26	Associação Para Desenvolvimento Do Centro Académico De Investigação E Formação Biomédica Do Algarve, Ad-Abc	Compounds and composition for dna protection

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2492258A1 (fr)	1980-10-17	1982-04-23	Pharmindustrie	Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
US4826860A (en)	1987-03-16	1989-05-02	Warner-Lambert Company	Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
FR2619713B1 (fr)	1987-08-25	1990-08-31	Rhone Poulenc Sante	Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement des troubles du sommeil et de la depression
FR2619712B1 (fr)	1987-08-25	1990-08-31	Rhone Poulenc Sante	Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la schizophrenie
FR2699077B1 (fr) *	1992-12-16	1995-01-13	Rhone Poulenc Rorer Sa	Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
FR2700116B1 (fr)	1993-01-07	1995-02-03	Rhone Poulenc Rorer Sa	Application d'anticonvulsivants comme radioprotecteurs.
FR2700117B1 (fr)	1993-01-07	1995-02-03	Rhone Poulenc Rorer Sa	Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR2702148B1 (fr) *	1993-03-05	1995-04-07	Rhone Poulenc Rorer Sa	Application d'anticonvulsivants dans le traitement du neuro-sida.
FR2714828B1 (fr) *	1994-01-12	1996-02-02	Rhone Poulenc Rorer Sa	Application du riluzole dans le traitement des maladies mitochondriales.
TW450807B (en) *	1995-09-15	2001-08-21	Pfizer	Pharmaceutical compositions for treating tinnitus comprising neuroprotective agents
DK0784973T3 (da) *	1995-10-10	2002-03-18	Pfizer	Quinoxalinderivater til behandling af tinnitus
ZA9610745B (en) *	1995-12-22	1997-06-24	Warner Lambert Co	4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
FR2787028B1 (fr) *	1998-12-15	2002-10-18	Aventis Pharma Sa	Utilisation du riluzole dans le traitement des traumatismes acoustiques

1998
- 1998-12-15 FR FR9815834A patent/FR2787028B1/fr not_active Expired - Fee Related
1999
- 1999-12-13 PT PT99958307T patent/PT1140080E/pt unknown
- 1999-12-13 CA CA002355359A patent/CA2355359C/fr not_active Expired - Fee Related
- 1999-12-13 AT AT99958307T patent/ATE278401T1/de active
- 1999-12-13 KR KR1020017007358A patent/KR100641473B1/ko not_active Expired - Fee Related
- 1999-12-13 UA UA2001063983A patent/UA72229C2/uk unknown
- 1999-12-13 IL IL14328099A patent/IL143280A0/xx active IP Right Grant
- 1999-12-13 HU HU0104698A patent/HU228889B1/hu not_active IP Right Cessation
- 1999-12-13 CZ CZ20012085A patent/CZ292078B6/cs not_active IP Right Cessation
- 1999-12-13 DE DE69920959T patent/DE69920959T2/de not_active Expired - Lifetime
- 1999-12-13 ES ES99958307T patent/ES2229796T3/es not_active Expired - Lifetime
- 1999-12-13 WO PCT/FR1999/003108 patent/WO2000035447A1/fr not_active Ceased
- 1999-12-13 AU AU15696/00A patent/AU773639B2/en not_active Ceased
- 1999-12-13 SK SK824-2001A patent/SK285206B6/sk not_active IP Right Cessation
- 1999-12-13 JP JP2000587767A patent/JP4831866B2/ja not_active Expired - Fee Related
- 1999-12-13 BR BR9916244-0A patent/BR9916244A/pt not_active Application Discontinuation
- 1999-12-13 EP EP99958307A patent/EP1140080B1/de not_active Expired - Lifetime
2001
- 2001-05-21 IL IL143280A patent/IL143280A/en not_active IP Right Cessation
- 2001-06-06 NO NO20012777A patent/NO326764B1/no not_active IP Right Cessation
- 2001-06-13 ZA ZA200104827A patent/ZA200104827B/en unknown
- 2001-06-15 US US09/882,223 patent/US6660757B2/en not_active Expired - Lifetime
2011
- 2011-07-14 JP JP2011155955A patent/JP5536722B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
PT1140080E (pt)	2005-01-31
KR20010101192A (ko)	2001-11-14
EP1140080B1 (de)	2004-10-06
NO20012777L (no)	2001-06-06
CZ292078B6 (cs)	2003-07-16
JP2011219497A (ja)	2011-11-04
SK285206B6 (sk)	2006-08-03
CA2355359A1 (fr)	2000-06-22
HUP0104698A2 (hu)	2002-04-29
CZ20012085A3 (cs)	2001-09-12
FR2787028A1 (fr)	2000-06-16
EP1140080A1 (de)	2001-10-10
KR100641473B1 (ko)	2006-10-31
AU773639B2 (en)	2004-05-27
NO20012777D0 (no)	2001-06-06
AU1569600A (en)	2000-07-03
US6660757B2 (en)	2003-12-09
JP5536722B2 (ja)	2014-07-02
SK8242001A3 (en)	2001-12-03
ES2229796T3 (es)	2005-04-16
DE69920959D1 (de)	2004-11-11
HU228889B1 (en)	2013-06-28
JP4831866B2 (ja)	2011-12-07
IL143280A0 (en)	2002-04-21
US20020004516A1 (en)	2002-01-10
JP2002532424A (ja)	2002-10-02
DE69920959T2 (de)	2005-09-01
HUP0104698A3 (en)	2004-05-28
NO326764B1 (no)	2009-02-09
UA72229C2 (en)	2005-02-15
FR2787028B1 (fr)	2002-10-18
ZA200104827B (en)	2002-09-13
IL143280A (en)	2007-10-31
CA2355359C (fr)	2009-02-03
BR9916244A (pt)	2001-10-02
WO2000035447A1 (fr)	2000-06-22

Similar Documents

Publication	Publication Date	Title
ATE357272T1 (de)	2007-04-15	Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten
DE59409832D1 (de)	2001-09-20	Pflaster zur behandlung von nagelmykosen
ATE325614T1 (de)	2006-06-15	Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen
ATE340171T1 (de)	2006-10-15	Piperazinderivate zur behandlung bakterieller infektionen
ATE350030T1 (de)	2007-01-15	Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE60037394D1 (de)	2008-01-24	VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE
ATE361752T1 (de)	2007-06-15	Methoden zur prophylaxe und behandlung von schäden der wahrnehmungshärchenzellen und der cochlearen neuronen
DE69532804D1 (de)	2004-05-06	Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
DE69401577D1 (de)	1997-03-06	Verabreichung von lamotrigin zur behandlung von neuro-aids
ATE214272T1 (de)	2002-03-15	Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
TR200101149T2 (tr)	2001-10-22	Dış retina bozukluklarının tedavisi.
DE50114605D1 (de)	2009-02-05	No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
ATE278401T1 (de)	2004-10-15	Verwendung von riluzol zur behandlung von akustischen traumazuständen
ATE222101T1 (de)	2002-08-15	Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
ATE234617T1 (de)	2003-04-15	Verwendung des saredutant und seiner pharmazeutisch akzeptablen salze zur behandlung von schwere depression
DE60018200D1 (de)	2005-03-24	Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
DE69626816D1 (de)	2003-04-24	Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ATE359808T1 (de)	2007-05-15	Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ATE261724T1 (de)	2004-04-15	Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
ATE294584T1 (de)	2005-05-15	Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
DK1133296T3 (da)	2003-11-17	Ny terapeutisk anvendelse af nicergolin
ATE236633T1 (de)	2003-04-15	Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE262362T1 (de)	2004-04-15	Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
DE60109594D1 (de)	2005-04-28	R-eliprodil zur behandlung von glaucoma
DE69936779D1 (de)	2007-09-20	Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen

Legal Events

Date

Code

Title

Description

2005-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1140080

Country of ref document: EP